EGFR and neoplasm: Besides, the inhibitory effect of FH-EB02 on phosphorylated EGFR (p-EGFR) was considerably weaker even at 250 nM (Fig. 3H), indicating selective inhibition EGFR signaling in tumor cells co-expressing EGFR and B7H3.